Documente Academic
Documente Profesional
Documente Cultură
Minireview
The p53 tumor suppressor protein acts as a major defense against cancer. Among its most
distinctive features is the ability to elicit both apoptotic death and cell cycle arrest. In
this issue of Cell, Das et al. (2007) and Tanaka et al. (2007) provide new insights into the
mechanisms that dictate the life and death decisions of p53.
Cells are incessantly bombarded by an assortment of envi- Basic Rules of p53-DNA Binding
ronmental and intrinsic factors that cause cellular damage. Sequence-specific DNA binding of p53 is a prerequisite
Although mild damage is often reparable, extensive dam- for the transactivation of target genes. Typically, p53
age poses a potential oncogenic danger. In the latter case, response elements (p53REs) are located within a few
the benefit of the organism calls for the eradication of the thousand nucleotides upstream or downstream from the
potentially life-threatening cells, which often is achieved transcription start site. Frequently, p53 targets contain
through activation of an apoptotic cell death program. at least two widely spaced p53REs. However, not all
Thus, the cell is continually faced with an agonizing choice: target genes are equally responsive to p53, suggesting
repair and live, or die. Defects in this decision process additional layers of regulation.
can lead to cancer, and insights into the mechanisms of DNA topology of p53REs may serve as one struc-
dysregulation can improve strategies for designing more tural determinant influencing promoter discrimination.
effective therapies. This cell fate choice often depends The fact that regions proximal to some p53REs (for
on the tumor suppressor protein p53. Sitting at the junc- example, those of the GADD45 and Mdm2 genes) exist
tion of an extremely complex network of cellular signaling, constitutively in open, non-nucleosome occupied states
p53 assimilates disparate input signals such as oncogene whereas others do not, might contribute to differential
activation, DNA damage, mitotic impairment or oxidative activation of p53 target genes (Braastad et al., 2003).
stress to initiate appropriate outputs—DNA repair, cell Furthermore, conformation of the DNA may be impor-
cycle arrest, senescence, or apoptosis (Harris and Levine, tant. The recognition of elements in the Mdm2 and p21
2005). This begs the question of how one molecule is able promoters is dependent on their differential propensities
to mediate such a wide spectrum of responses. to adopt non-B-DNA conformations (Kim and Deppert,
Even though p53 can also function in a transcrip- 2003). More generally, the binding affinities of p53 for
tion-independent manner (Fuster et al., 2007), the best specific p53REs differ widely; high affinity sites tend to
understood functions of p53 have been attributed to its associate with growth arrest-related genes, whereas low
transcriptional activity. In fact, approximately half of all affinity sites are more frequent in proapoptotic genes
cancers bear p53 gene mutations, the vast majority of (Inga et al., 2002).
which impair the ability of p53 to act as a sequence- The different affinities of p53 toward different p53REs
specific transcriptional activator. This underscores the suggest that levels of p53 protein may profoundly affect
importance of p53-regulated genes for p53’s tumor sup- promoter choice and cell fate. Indeed, low p53 levels
pressor activity. tend to favor growth arrest, whereas higher levels over-
How p53 “knows” which genes to turn on or off in ride this default pathway and trigger apoptosis (Lap-
order to achieve the desirable outcome has been a tenko and Prives, 2006). This might explain, at least in
focus of intensive research (Harris and Levine, 2005; part, why binding to proapoptotic promoters, such as
Laptenko and Prives, 2006). Particular effort has been PIG3, is markedly delayed relative to binding to cell cycle
devoted to understanding how p53 is instructed to favor arrest promoters such as p21 (Szak et al., 2001).
activation of growth-inhibitory genes in response to lim-
ited damage that calls for a transient cell cycle arrest in p53 Binding Proteins and the Transcriptional
conjunction with repair, and activation of proapoptotic Response
genes in response to extensive irreparable damage. Two Not surprisingly, the interaction between p53 and its DNA
exciting reports (Das et al., 2007; Tanaka et al., 2007) in target sequences is highly influenced by the cellular con-
this issue describe two new partners for p53—the zinc text. A plethora of partner proteins have been implicated in
finger protein Hzf and the chromatin-associated protein modulating the selection of p53 targets (Figure 1). Some of
CAS/CSE1L—that are involved in opposite arms of the those proteins are transcription factors themselves, which
p53 response. presumably bind to promoter sites adjacent to p53REs to
selectively induce specific response genes. Others influ- of the cell cycle. Once in the nucleus, the N-terminal frag-
ence the ability of p53 itself to bind preferentially to par- ment of YB1 directly binds to p53 to prevent transactiva-
ticular DNA target sequences and not to others. The cellu- tion of proapoptotic genes (Homer et al., 2005).
lar environment as well as the relative abundance of these The transcription factor NF-κB is also an important
potential partners under different conditions could obvi- modulator of p53 transcriptional activity. While often
ously tip the life-or-death balance of p53 activity. antagonizing p53 function, NF-κB can also sometimes
ASPP family proteins comprise three members: cooperate with p53. NF-κB negatively affects p53 protein
ASPP1, ASPP2 and inhibitory ASPP (iASPP) (Sullivan levels via positive regulation of Mdm2 expression. Com-
and Lu, 2007). Upon DNA damage, ASPP1 and 2 are petition for coactivators, such as p300 and CBP, might
activated and then interact with the DNA binding domain provide additional means for mutual negative regulation.
(DBD) of p53, enhancing its tumor suppressor activity. Recent data indicate that phosphorylation of CBP by
Specifically, they enhance p53’s apoptotic capabilities IKKα, which occurs excessively in certain human can-
by guiding p53 to the promoters of proapoptotic genes, cers, can direct CBP to bind preferentially to NF-κB and
such as Bax and PIG3, but not to the promoters of pro- not p53, thereby favoring proliferation and survival over
arrest genes such as p21 or regulatory genes such as p53-dependent apoptosis (Huang et al., 2007). There is
Mdm2. In accordance with their potential tumor sup- also crosstalk between p53 and the NF-κB subunit p52.
pressor activity, ASPP1 and 2 are frequently downregu- Under some conditions, p52 can be recruited directly to
lated in human tumors (Sullivan and Lu, 2007). In con- p53 target promoters, leading to repression of p21 and
trast iASPP, which counters the effects of ASPP1 and 2 activation of proapoptotic DR5 and PUMA (Schumm et
and interferes with activation of proapoptotic genes, is al., 2006), thus tipping the balance toward apoptosis and
often overexpressed in human tumors. away from cell cycle arrest.
The Brn3 family of POU domain transcription factors A number of additional p53-interacting proteins,
also modulates p53 target selectivity. Whereas Brn3b including the p63 and p73 members of the p53 family,
augments the activation of proapoptotic genes, such can also modulate promoter choice by p53, even though
as Bax (Budhram-Mahadeo et al., 2006), Brn3a has the the exact underlying mechanisms remain to be eluci-
opposite effect. Brn3a and p53 directly interact dur- dated (Laptenko and Prives, 2006).
ing neuronal differentiation to mutually modulate their In their new work, Das et al. (2007) report that the zinc
respective transcriptional outputs. In that role, Brn3a finger protein Hzf, encoded by a gene previously shown to
diminishes the ability of p53 to transactivate the Bax pro- be a p53 target (Sugimoto et al., 2006), directly interacts
moter, while stimulating transcription of p21, resulting in with the p53 DBD, inducing preferential expression of p53
a net outcome of cell cycle arrest rather than apoptosis. target genes that block the cell cycle. Thus, Hzf favors the
YB1 is a DNA binding protein overexpressed in many transactivation of p21 and 14-3-3σ genes while simultane-
tumor types. Stress signals trigger proteolytic cleavage of ously attenuating transcription of proapoptotic genes such
YB1 and p53-dependent nuclear import at the G1/S stage as Bax, Perp, Puma and Noxa (Das et al., 2007). The Mdm2
versus severe DNA damage. Nevertheless, the findings of Sugimoto, M., Gromley, A., and Sherr, C.J. (2006). Mol. Cell. Biol. 26,
Tanaka et al. imply that much of the target gene selectivity 502–512.
of p53 may be orchestrated not only at the level of binding Sullivan, A., and Lu, X. (2007). Br. J. Cancer 96, 196–200.
of p53 to its response elements within the DNA, but also at
the level of gene-specific chromatin modifications dictated Sykes, S.M., Mellert, H.S., Holbert, M.A., Li, K., Marmorstein, R., Lane,
W.S., and McMahon, S.B. (2006). Mol. Cell 24, 841–851.
by the particular preferences of proteins such as CAS.
Szak, S.T., Mays, D., and Pietenpol, J.A. (2001). Mol. Cell. Biol. 21,
3375–3386.
Concluding Remarks
A future challenge is to understand the crosstalk Tanaka, T., Ohkubo, S., Tatsuno, I., and Prives, C. (2007). Cell, this
between these diverse regulators of p53 target gene issue.
choice. Other factors, including cell type, absence or Tang, Y., Luo, J., Zhang, W., and Gu, W. (2006). Mol. Cell 24, 827–
presence of other transcription factors, and cellular 839.